Integrin Binding Peptide

Product Name: Integrin Binding Peptide

Sequence One Letter Code: Ac-GCGYGRGDSPG-NH2

Sequence Three Letter Code: Ac-Gly-Cys-Gly-Tyr-Gly-Arg-Gly-Asp-Ser-Pro-Gly-NH2

Chemical Formula:C42 H63 N15 O16 S

Molecular Weight: 1066.2

Purity: 95%

Form: Lyophilized

Storage Conditions: - 20 °C

Research Area: Peptide Series

Source / Species: synthetic

Conjugation: Unconjugated

Code Nacres: NA.26

Application: This integrin-binding peptide, derived from fibronectin, contains adhesion motifs that engage integrin receptors to promote cell attachment and signaling. It is frequently incorporated into polyethylene glycol (PEG) hydrogels and other synthetic matrices to enhance biocompatibility and regulate cell–material interactions. By mimicking extracellular matrix cues, the peptide supports controlled studies of cell adhesion, spreading, migration, and mechanotransduction. It is widely used in tissue engineering, regenerative medicine, and biomaterials research to optimize scaffold design and modulate cellular behavior within engineered microenvironments.

Current Research: Cell adhesion to the extracellular matrix (ECM) is a fundamental process that regulates cellular survival, migration, differentiation, and mechanotransduction. These interactions are largely mediated by integrin receptors, a family of transmembrane proteins that recognize specific peptide motifs within ECM proteins such as fibronectin, collagen, and laminin. To replicate these biological cues in engineered materials, researchers frequently employ fibronectin-derived integrin-binding peptides containing adhesion motifs capable of engaging integrin receptors. These peptides have become essential tools in biomaterials research, particularly for modifying synthetic scaffolds and hydrogels to improve cell–material interactions. One of the most active areas of research involves incorporating integrin-binding peptides into polyethylene glycol (PEG) hydrogels and other synthetic polymer matrices. PEG-based materials are widely used in tissue engineering due to their chemical stability, tunable mechanical properties, and minimal intrinsic bioactivity. However, because PEG is biologically inert, it does not naturally support cell attachment. By conjugating fibronectin-derived adhesion peptides to PEG networks, researchers can introduce specific integrin-binding sites that promote cell adhesion, spreading, and cytoskeletal organization. This approach allows scientists to precisely control the biochemical signals presented to cells within engineered microenvironments. Recent studies have focused on understanding how integrin-mediated signaling influences cell behavior within biomaterials. When integrins bind to adhesive peptides, they cluster at the cell membrane and initiate intracellular signaling cascades that regulate actin cytoskeleton dynamics, focal adhesion formation, and gene expression. By varying peptide density, spatial distribution, or presentation within hydrogels, researchers can investigate how cells respond to different adhesion conditions. These studies provide insights into how mechanical and biochemical cues interact to influence processes such as cell migration, proliferation, and differentiation. Another important research direction involves the use of integrin-binding peptides to study mechanotransduction, the process by which cells convert mechanical forces into biochemical signals. Engineered hydrogels functionalized with fibronectin-derived peptides allow investigators to modulate substrate stiffness and ligand availability independently. This experimental control enables detailed analysis of how integrin engagement and matrix mechanics jointly regulate cellular responses. For example, stem cells cultured on peptide-functionalized hydrogels can exhibit different differentiation pathways depending on the mechanical properties of the surrounding matrix and the availability of integrin-binding ligands. Fibronectin-derived adhesion peptides are also widely applied in regenerative medicine and tissue engineering strategies. In scaffold design, these peptides improve the integration of biomaterials with host tissues by enhancing cell attachment and promoting tissue formation. Peptide-modified scaffolds have been investigated for applications in bone regeneration, vascular tissue engineering, wound healing, and neural repair. By mimicking natural ECM signaling, these materials create microenvironments that support tissue regeneration while maintaining the structural advantages of synthetic biomaterials. Another emerging area of research involves three-dimensional (3D) cell culture systems and organoid models. Integrin-binding peptides incorporated into hydrogels enable researchers to recreate ECM-like environments that more accurately mimic physiological conditions compared with traditional two-dimensional culture systems. Cells cultured within peptide-functionalized 3D matrices display more realistic morphology, gene expression patterns, and cellular interactions, making these systems valuable for studying tissue development, disease progression, and drug responses. Advances in biomaterial engineering and peptide chemistry have further expanded the versatility of these integrin-binding motifs. Researchers can now control peptide orientation, spacing, and multivalency within polymer networks, allowing systematic investigation of how ligand presentation influences integrin activation and downstream signaling. Such studies are helping to refine the design of next-generation biomaterials with improved biological performance. In summary, fibronectin-derived integrin-binding peptides play a critical role in modern biomaterials research by enabling the incorporation of biologically relevant adhesion signals into synthetic matrices. Through applications in hydrogel functionalization, mechanotransduction studies, and regenerative scaffold design, these peptides provide a powerful platform for investigating cell–matrix interactions and optimizing engineered microenvironments. Ongoing research continues to leverage these peptide motifs to advance tissue engineering technologies and improve strategies for regenerative medicine.